Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 20, 2012 - Issue 6
Submit an article Journal homepage
673
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Immunohistochemical Evidence of Specific Iris Involvement in Blau Syndrome

Stella C. PaparizosDepartment of Ophthalmology, Summa Health System, Akron, Ohio, USA
, MD,
Debra A. GoldsteinDepartment of Ophthalmology and Visual Sciences, University of Illinois, Chicago, Illinois, USA
, MD,
Rachida A. BouhenniDepartment of Ophthalmology, Summa Health System, Akron, Ohio, USA
, Phd,
Scott SteinerDepartment of Ophthalmology and Visual Sciences, University of Illinois, Chicago, Illinois, USA
, MD,
Jeffrey J. DunmireDepartment of Ophthalmology, Summa Health System, Akron, Ohio, USA
, BS &
Deepak P. EdwardDepartment of Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; and Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USACorrespondence[email protected]
, MD
Pages 471-474 | Received 25 Mar 2012, Accepted 29 Aug 2012, Published online: 07 Dec 2012

REFERENCES

  • Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. Nov 1985;107(5):689–693.
  • Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. Sep 2001;29(1):19–20.
  • Chamaillard M, Philpott D, Girardin SE, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A. Mar 2003;100(6):3455–3460.
  • Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin Immunol. Mar; 2010;134(3):251–261.
  • Kwon MY, Liu X, Lee SJ, et al. Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury. Arterioscler Thromb Vasc Biol. Nov 2011;31(11):2441–2447.
  • Davey MP, Martin TM, Planck SR, Lee J, Zamora D, Rosenbaum JT. Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvasc Res. Mar 2006;71(2):103–107.
  • Janssen CE, Rose CD, De Hertogh G, et al. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease. J Allergy Clin Immunol. Apr 2012;129(4):1076–1084.
  • Okafuji I, Nishikomori R, Kanazawa N, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. Jan 2009;60(1):242–250.
  • Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology. Oct 2003;110(10):2040–2044.
  • Jimenez-Martinez MC, Cruz F, Groman-Lupa S, Zenteno JC. Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation. Int J Immunogenet. Jun 2011;38(3):233–242.
  • Granzotto M, Fabbro E, Maschio M, et al. Heterozygous nucleotide-binding oligomerization domain-2 mutations affect monocyte maturation in Crohn’s disease. World J Gastroenterol. Dec 2007;13(46):6191–6196.
  • Ewida AS, Raphael SA, Abbasi JA, Geslani GP, Bagasra O. Evaluation of Th-1 and Th-2 immune responses in the skin lesions of patients with Blau syndrome. Appl Immunohistochem Mol Morphol. Jun 2002;10(2):171–177.
  • Rosenzweig HL, Kawaguchi T, Martin TM, Planck SR, Davey MP, Rosenbaum JT. Nucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-gamma. Invest Ophthalmol Vis Sci. Apr 2009;50(4):1739–1745.
  • McMenamin PG, Crewe J, Morrison S, Holt PG. Immunomorphologic studies of macrophages and MHC class II-positive dendritic cells in the iris and ciliary body of the rat, mouse, and human eye. Invest Ophthalmol Vis Sci. Jul 1994;35(8):3234–3250.
  • Flugel C, Kinne RW, Streilein JW, Lutjen-Drecoll E. Distinctive distribution of HLA class II presenting and bone marrow derived cells in the anterior segment of human eyes. Curr Eye Res. Dec 1992;11(12):1173–1183.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.